Company intelligence / Profile preview

NexPoint Capital

Dallas, TX, USA

Ownership: Private
Development stage: Other

Overview

NexPoint Capital is a business development company (BDC) that operates as part of NexPoint, a Dallas-based alternative investment platform with a significant strategic focus on the life sciences and healthcare sectors. While not a drug developer itself, the firm provides debt and equity capital to middle-market companies, including those in healthcare services and biotechnology. NexPoint is notably recognized for its massive investments in life science infrastructure, including the development of the NexPoint Life Sciences Innovation District, a multi-billion dollar research and development campus in Plano, Texas. The firm's broader life sciences strategy integrates private equity, credit, and real estate investments to support the growth of the biotechnology ecosystem.

Industry: Investors

Beyond the preview

Go deeper on NexPoint Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NexPoint Capital.

Explore the full profile